Research ArticleExperimental Studies

AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer

SHUNSUKE NAKAMURA, MITSURO KANDA, DAI SHIMIZU, CHIE TANAKA, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, SUGURU YAMADA, GORO NAKAYAMA, KENJI OMAE, MASAHIKO KOIKE and YASUHIRO KODERA
Anticancer Research December 2020, 40 (12) 6713-6721; DOI: https://doi.org/10.21873/anticanres.14694

Article Figures & Data

Figures

  • Figure 1.
    Figure 1.

    Analysis of AMIGO2 expression in 14 gastric cancer cell lines. (A) The levels of AMIGO2 mRNA in gastric cancer cell lines. (B) PCR array analysis.

  • Figure 2.
    Figure 2.

    Comparison of AMIGO2 mRNA levels in normal adjacent tissues and GC tissues as a function of UICC stage. *p<0.05.

  • Figure 3.
    Figure 3.

    Clinical significance of AMIGO2 mRNA expression. (A) Kaplan–Meier analysis of disease-free survival (DFS) and overall survival (OS) rates of the institutional and external validation cohorts. (B) Frequencies of initial recurrence after curative gastrectomy in patients according to AMIGO2 mRNA levels. *p<0.05.

Tables

  • Table I.
  • Table II.
  • Table III.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer
SHUNSUKE NAKAMURA, MITSURO KANDA, DAI SHIMIZU, CHIE TANAKA, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, SUGURU YAMADA, GORO NAKAYAMA, KENJI OMAE, MASAHIKO KOIKE, YASUHIRO KODERA
Anticancer Research Dec 2020, 40 (12) 6713-6721; DOI: 10.21873/anticanres.14694
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords